Australia’s MedTech and Pharmaceutical industry growth centre MTPConnect is warning antimicrobial resistant ‘superbugs’ could cause 10,000 deaths annually by 2050 if immediate action to correct a research and development market failure isn’t taken by the federal government. The industry growth centre estimates that antimicrobial resistant pathogens could cost the Australian economy up to $283 billion…

The post Superbugs loom in antimicrobial innovation gap appeared first on InnovationAus.com.

This post was originally published on InnovationAus.com.